Phoebe Rich

Professor

  • 4181 Citations
  • 34 h-Index
1982 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Phoebe Rich is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Nails Medicine & Life Sciences
Onychomycosis Medicine & Life Sciences
Psoriasis Medicine & Life Sciences
terbinafine Medicine & Life Sciences
Nail Diseases Medicine & Life Sciences
Safety Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Placebos Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1982 2019

Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trial

Elewski, B. E., Baker, C. S., Crowley, J. J., Poulin, Y., Okun, M. M., Calimlim, B., Geng, Z., Reyes Servin, O. & Rich, P., Jan 1 2019, (Accepted/In press) In : Journal of the European Academy of Dermatology and Venereology.

Research output: Contribution to journalArticle

Open Access
Nails
Psoriasis
Randomized Controlled Trials
Placebos
Safety

A Randomized, Vehicle-Controlled Phase 3 Study of Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses on the Upper Extremities

Brian Jiang, S. I., Kempers, S., Rich, P., Marcus, S., Houlihan, A., Piacquadio, D. & Pariser, D., Jul 1 2019, In : Dermatologic Surgery. 45, 7, p. 890-897 8 p.

Research output: Contribution to journalArticle

Actinic Keratosis
Aminolevulinic Acid
Photochemotherapy
Upper Extremity
Occlusive Dressings

Conservative Treatment of Retronychia: A Retrospective Study of 25 Patients

Laird, M. E., Lo Sicco, K. I. & Rich, P., Apr 1 2019, In : Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 45, 4, p. 614-616 3 p.

Research output: Contribution to journalArticle

Retrospective Studies
Conservative Treatment
6 Citations (Scopus)
Psoriasis
Safety
Placebos
Interleukin-23
Therapeutics
Melanocytes
MART-1 Antigen
Nails
Melanoma
Coloring Agents